MedTrace Logo

Pivotal Observational CHLOE Study

NCT06111365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2025-03-19

No results posted yet for this study

Summary

This pivotal study is an observational, prospective assessment, multi-center, databank based, clinical study aimed to evaluate the performance of CHLOE™ algorithm in prediction of blastocyst formation.

Conditions

  • IVF

Interventions

DEVICE

CHLOE

the system will provide to the user a "CHLOE™ score", which is a blastocyst development prediction value, a discrete grading for blastocyst associated with the likelihood of the embryo reaching the blastocyst stage at Day 5

Sponsors & Collaborators

  • Fairtility

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-22
Primary Completion
2024-08-12
Completion
2024-08-12
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06111365 on ClinicalTrials.gov